Discrepancy remains in pharmaceutical prescriptions in four European countriesBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7163.947 (Published 03 October 1998) Cite this as: BMJ 1998;317:947
- Silvio Garattini, Director,
- Livio Garattini, Director.
- Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
- Centro di Economia Sanitaria “A. Valenti” (CESAV) Ranica (BG), Italy
EDITOR—Several years ago we reported the drugs that had been most widely sold by value in four countries in Europe (France, Germany, Italy, and the United Kingdom) in 1992.1 We report here the drug sales in the same countries in 1996.
We firstly established how many of the 50 products that were most widely sold in the four countries did not have appropriate documentation of efficacy. In France, Germany, and Italy …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial